Benjamin H Rotstein1, Steven H Liang1, Michael S Placzek2, Jacob M Hooker3, Antony D Gee4, Frédéric Dollé5, Alan A Wilson6, Neil Vasdev1. 1. Massachusetts General Hospital, Harvard Medical School, Boston, USA. vasdev.neil@mgh.harvard.edu. 2. Athinoula A. Martinos Center for Biomedical Imaging, MGH, HMS, Charlestown, USA and McLean Hospital, Belmont, USA. 3. Athinoula A. Martinos Center for Biomedical Imaging, MGH, HMS, Charlestown, USA. 4. King's College London, London, UK. 5. CEA - Institut d'imagerie biomédicale, Service hospitalier Frédéric Joliot, Université Paris-Saclay, Orsay, France. 6. Centre for Addiction and Mental Health, Toronto, Canada.
Abstract
The positron-emitting radionuclide carbon-11 ((11)C, t1/2 = 20.3 min) possesses the unique potential for radiolabeling of any biological, naturally occurring, or synthetic organic molecule for in vivo positron emission tomography (PET) imaging. Carbon-11 is most often incorporated into small molecules by methylation of alcohol, thiol, amine or carboxylic acid precursors using [(11)C]methyl iodide or [(11)C]methyl triflate (generated from [(11)C]carbon dioxide or [(11)C]methane). Consequently, small molecules that lack an easily substituted (11)C-methyl group are often considered to have non-obvious strategies for radiolabeling and require a more customized approach. [(11)C]Carbon dioxide itself, [(11)C]carbon monoxide, [(11)C]cyanide, and [(11)C]phosgene represent alternative reactants to enable (11)C-carbonylation. Methodologies developed for preparation of (11)C-carbonyl groups have had a tremendous impact on the development of novel PET tracers and provided key tools for clinical research. (11)C-Carbonyl radiopharmaceuticals based on labeled carboxylic acids, amides, carbamates and ureas now account for a substantial number of important imaging agents that have seen translation to higher species and clinical research of previously inaccessible targets, which is a testament to the creativity, utility and practicality of the underlying radiochemistry.
The positron-emitting radionucliden class="Chemical">carbon-11 ((11)C, t1/2 = 20.3 min) possesses the unique potential for radiolabeling of any biological, naturally occurring, or synthetic organic molecule for in vivo positron emission tomography (PET) imaging. Carbon-11 is most often incorporated into small molecules by methylation of alcohol, thiol, amine or carboxylic acid precursors using [(11)C]methyl iodide or [(11)C]methyl triflate (generated from [(11)C]carbon dioxide or [(11)C]methane). Consequently, small molecules that lack an easily substituted (11)C-methyl group are often considered to have non-obvious strategies for radiolabeling and require a more customized approach. [(11)C]Carbon dioxide itself, [(11)C]carbon monoxide, [(11)C]cyanide, and [(11)C]phosgene represent alternative reactants to enable (11)C-carbonylation. Methodologies developed for preparation of (11)C-carbonyl groups have had a tremendous impact on the development of novel PET tracers and provided key tools for clinical research. (11)C-Carbonyl radiopharmaceuticals based on labeled carboxylic acids, amides, carbamates and ureas now account for a substantial number of important imaging agents that have seen translation to higher species and clinical research of previously inaccessible targets, which is a testament to the creativity, utility and practicality of the underlying radiochemistry.
Authors: Patrik Nordeman; Stig D Friis; Thomas L Andersen; Hélène Audrain; Mats Larhed; Troels Skrydstrup; Gunnar Antoni Journal: Chemistry Date: 2015-10-23 Impact factor: 5.236
Authors: Berend van der Wildt; Micha M M Wilhelmus; Jonne Bijkerk; Lizeth Y F Haveman; Esther J M Kooijman; Robert C Schuit; John G J M Bol; Cornelis A M Jongenelen; Adriaan A Lammertsma; Benjamin Drukarch; Albert D Windhorst Journal: Nucl Med Biol Date: 2016-02-02 Impact factor: 2.408
Authors: Justin W Hicks; Jun Parkes; Oleg Sadovski; Junchao Tong; Sylvain Houle; Neil Vasdev; Alan A Wilson Journal: Nucl Med Biol Date: 2013-05-31 Impact factor: 2.408
Authors: Joost Verbeek; Jonas Eriksson; Stina Syvänen; Maaike Labots; Elizabeth C M de Lange; Rob A Voskuyl; Martinus P J Mooijer; Marissa Rongen; Adriaan A Lammertsma; Albert D Windhorst Journal: EJNMMI Res Date: 2012-07-02 Impact factor: 3.138
Authors: Xiaoyun Deng; Jian Rong; Lu Wang; Neil Vasdev; Lei Zhang; Lee Josephson; Steven H Liang Journal: Angew Chem Int Ed Engl Date: 2019-01-14 Impact factor: 15.336
Authors: Kenneth Dahl; Thomas L Collier; Ran Cheng; Xiaofei Zhang; Oleg Sadovski; Steven H Liang; Neil Vasdev Journal: J Labelled Comp Radiopharm Date: 2017-07-25 Impact factor: 1.921
Authors: Ran Cheng; Wakana Mori; Longle Ma; Mireille Alhouayek; Akiko Hatori; Yiding Zhang; Daisuke Ogasawara; Gengyang Yuan; Zhen Chen; Xiaofei Zhang; Hang Shi; Tomoteru Yamasaki; Lin Xie; Katsushi Kumata; Masayuki Fujinaga; Yuji Nagai; Takafumi Minamimoto; Mona Svensson; Lu Wang; Yunfei Du; Mary Jo Ondrechen; Neil Vasdev; Benjamin F Cravatt; Christopher Fowler; Ming-Rong Zhang; Steven H Liang Journal: J Med Chem Date: 2018-03-09 Impact factor: 7.446